ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
雍和植髮(臨時代碼)
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
市銷率:
- -
資料載入中...
總覽
公司
新聞資訊
公告
康方生物:本公司創新藥物CD73單克隆抗體完成首例健康受試者給藥
新浪财经
·
2020/10/27
康方生物:本公司董事會宣佈,其自主研發的創新藥物CD73單克隆抗體在新西蘭...
新浪财经
·
2020/10/27
港股醫藥股走強 康方生物漲近8%康龍化成漲近5%
新浪港股
·
2020/10/12
康方生物-B(09926):派安普利聯合化療一線治療轉移性鱗狀非小細胞肺癌III期臨床試驗完成入組
智通财经网
·
2020/10/12
康方生物-B(09926):派安普利單抗(PD-1)治療三線鼻咽癌註冊性臨床試驗達到主要終點
智通财经网
·
2020/10/12
康方生物-B:派安普利單抗(PD-1)治療臨床達主要終點
新浪港股
·
2020/10/12
被退回兩月後 康方生物再次申請赴港上市
新浪财经-自媒体综合
·
2020/02/28
康方生物再遞招股書 鉅額虧損不改赴港上市的決心
新浪财经-自媒体综合
·
2020/02/14
二度闖關港股IPO的康方生物:欲借雙抗逆襲
新浪财经-自媒体综合
·
2020/02/13
新股速遞 | 康方生物,雙抗比信達、康寧起步更早的生物製藥企業
华盛学院
·
2020/02/11
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/90010/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90010","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","market":"HK","secType":"STK","nameCN":"雍和植髮(臨時代碼)","latestPrice":0,"timestamp":1776412800000,"preClose":0,"halted":8,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"04-17 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":5,"symbolChange":{"newSymbol":"09926","executeDate":"2020-04-14"},"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90010\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2020-04-14","symbol":"90010","oldSymbol":"90010","newSymbol":"09926","exchange":"SEHK","type":"symbolChange","dateTimestamp":1586793600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90010\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90010\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90010\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2078092245","title":"康方生物:本公司創新藥物CD73單克隆抗體完成首例健康受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2078092245","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2078092245?lang=zh_tw&edition=fundamental","pubTime":"2020-10-27 06:26","pubTimestamp":1603751160,"startTime":"0","endTime":"0","summary":"原标题:康方生物:本公司创新药物CD73单克隆抗体完成首例健康受试者给药 来源:新浪财经康方生物:本公司董事会宣布,其自主研发的创新药物CD73单克隆抗体在新西兰的临床试验完成首例健康受试者给药,AK119拟用于治疗新型冠状病毒患者。目前AK119在美国用于治疗轻中度COVID—19患者的临床试验已经获得美国食品药品监督管理局(FDA)的反馈,其同意本公司递交新药临床试验申请。","market":"sh","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-10-27/doc-iiznctkc7835166.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-10-27/doc-iiznctkc7835166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90014","09926","90010","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2078509222","title":"康方生物:本公司董事會宣佈,其自主研發的創新藥物CD73單克隆抗體在新西蘭...","url":"https://stock-news.laohu8.com/highlight/detail?id=2078509222","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2078509222?lang=zh_tw&edition=fundamental","pubTime":"2020-10-27 06:15","pubTimestamp":1603750521,"startTime":"0","endTime":"0","summary":"康方生物:本公司董事会宣布,其自主研发的创新药物CD73单克隆抗体在新西兰的临床试验完成首例健康受试者给药,AK119拟用于治疗新型冠状病毒患者。目前AK119在美国用于治疗轻中度COVID—19患者的临床试验已经获得美国食品药品监督管理局(FDA)的反馈,其同意本公司递交新药临床试验申请。","market":"us","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2020-10-27/doc-iiznctkc7833699.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2020-10-27/doc-iiznctkc7833699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["06978","159992","09926","90014","90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2074119805","title":"港股醫藥股走強 康方生物漲近8%康龍化成漲近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2074119805","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2074119805?lang=zh_tw&edition=fundamental","pubTime":"2020-10-12 09:44","pubTimestamp":1602467040,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://static.tigerbbs.com/de0bbe341ac5d74e1a8d74c9ca5de715","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/de0bbe341ac5d74e1a8d74c9ca5de715"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2020-10-12/doc-iivhvpwz1520862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","03759","09939","09926","300759","90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2074035818","title":"康方生物-B(09926):派安普利聯合化療一線治療轉移性鱗狀非小細胞肺癌III期臨床試驗完成入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2074035818","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2074035818?lang=zh_tw&edition=fundamental","pubTime":"2020-10-12 08:16","pubTimestamp":1602461789,"startTime":"0","endTime":"0","summary":"康方生物-B(09926)发布公告,该公司与中国生物制药有限公司(01177)共同...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/345115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03347","09926","90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2074033318","title":"康方生物-B(09926):派安普利單抗(PD-1)治療三線鼻咽癌註冊性臨床試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2074033318","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2074033318?lang=zh_tw&edition=fundamental","pubTime":"2020-10-12 08:07","pubTimestamp":1602461248,"startTime":"0","endTime":"0","summary":"康方生物-B(09926)发布公告,该公司与中国生物制药有限公司(01177)共同...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/345110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["90010","09926","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2074580358","title":"康方生物-B:派安普利單抗(PD-1)治療臨床達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2074580358","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2074580358?lang=zh_tw&edition=fundamental","pubTime":"2020-10-12 08:07","pubTimestamp":1602461220,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2020-10-12/doc-iivhuipp9120396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["90010","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2014809591","title":"被退回兩月後 康方生物再次申請赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2014809591","media":"新浪财经-自媒体综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2014809591?lang=zh_tw&edition=fundamental","pubTime":"2020-02-28 21:27","pubTimestamp":1582896420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2020-02-28/doc-iimxyqvz6609470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2011371813","title":"康方生物再遞招股書 鉅額虧損不改赴港上市的決心","url":"https://stock-news.laohu8.com/highlight/detail?id=2011371813","media":"新浪财经-自媒体综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2011371813?lang=zh_tw&edition=fundamental","pubTime":"2020-02-14 08:03","pubTimestamp":1581638580,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/newstock/zrzdt/2020-02-14/doc-iimxxstf1269781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2011919762","title":"二度闖關港股IPO的康方生物:欲借雙抗逆襲","url":"https://stock-news.laohu8.com/highlight/detail?id=2011919762","media":"新浪财经-自媒体综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2011919762?lang=zh_tw&edition=fundamental","pubTime":"2020-02-13 18:44","pubTimestamp":1581590640,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2020-02-13/doc-iimxyqvz2606978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["90010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2011797533","title":"新股速遞 | 康方生物,雙抗比信達、康寧起步更早的生物製藥企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2011797533","media":"华盛学院","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2011797533?lang=zh_tw&edition=fundamental","pubTime":"2020-02-11 11:34","pubTimestamp":1581392080,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-11/doc-iimxyqvz1928549.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-02-11/doc-iimxyqvz1928549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["GLW","90010","09966"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":112,"code":"91000000","status":"200"}]}}